• About Us
  • Our Editorial Policy
  • Business Directory
  • Advertise with Us
  • Our Advertisers
  • Contact Us
Australia India News
  • Alluring India - Brisbane Banner
India News Australia
  • Home
  • Current Issue
    Past Issue
  • India News
  • Business
  • World
    World This Week
  • Community News
  • What's On
  • Others
    Yoga in Australia News COVID-19 Community News Naari IPL News Health Travel Entertainment
  • National Events
  • Alluring India 2026
  • Please wait..
Business and Trade news

AstraZeneca Pharma India’s net profit slips 4 pc in Q1

  • BY India News Newsdesk
  • August 14, 2025
  • 0 COMMENTS

Mumbai, Aug 14 (IANS) AstraZeneca Pharma India Limited on Thursday reported a 4.12 per cent decline in net profit for the first quarter (Q1) of FY26, with earnings falling to Rs 55.8 crore from Rs 58.2 crore in the previous quarter (Q4 FY25).

This dip came despite a strong rise in revenue from operations, which grew 9.56 per cent sequentially to Rs 526.3 crore from Rs 480.4 crore, according to its stock exchange filing.

Other income saw a sharp decline of 30.43 per cent, dropping to Rs 11.2 crore from Rs 16.1 crore in Q4 FY25.

However, total income rose 8.23 per cent to Rs 537.5 crore from Rs 496.6 crore, driven by solid operational performance.

Total expenses increased by 12.12 per cent to Rs 462.4 crore, compared to Rs 412.4 crore in the previous quarter, the company stated in its regulatory filing.

Bhavana Agrawal, Chief Financial Officer and Director of the Company, said the strong quarterly performance reflects the power of science-led innovation combined with disciplined execution.

“Each regulatory milestone brings us closer to transforming outcomes for patients living with chronic diseases. We remain focused on expanding our portfolio, strengthening partnerships, and ensuring that breakthrough medicines reach the people who need them most,” she added.

Praveen Rao Akkinepally, Country President and Managing Director, said that delivering consistent growth across therapy areas reaffirms the strength of the company’s “Growth Through Innovation” strategy.

“These results are a testament to what is possible when science and purpose come together,” he noted.

AstraZeneca, a global science-led biopharmaceutical company, focuses on the discovery, development, and commercialisation of prescription medicines, primarily in oncology, cardiovascular, renal and metabolism, respiratory, and rare diseases.

The company operates in over 100 countries, with its medicines used by millions of patients worldwide.

Completing 45 years in India, AstraZeneca Pharma India Limited is headquartered in Bengaluru and employs over 600 people across the country.

–IANS

pk

Post navigation

Jharkhand man kills wife over suspicion of affair, commits suicide
Kho Kho WC winners to attend Independence Day celebrations at Red Fort for first time

Related Post

Uber’s Prabhjeet Singh to join OpenAI as Managing Director for India operations
June 27, 2026
Trump warns Europe over digital tax with 100 pc tariff
June 27, 2026
India a key tech partner, says US official after Pax Silica launch
June 27, 2026
Supply chain risks go beyond China: US
June 27, 2026

Our Current Issue

Alluring India 2026

Alluring India 2026

Our Advertisers

  • Battery Rebate australia
  • Bess Australia Solar Panels
  • Alluring India - Brisbane 2026

Follow Us

  • facebook
  • facebook
  • facebook
  • facebook
INDIA NEWS on YouTube in Australia, bring to our readers and subscribers national and international news, editorials, expert columns, community activities and interviews of political leaders, celebrities, business professionals, academics and sport personalities among others.
  • facebook
  • facebook
  • facebook
  • facebook

Category

  • Accident
  • Adani Australia
  • Advertorial
  • Alluring India 2026
  • Arts & Culture
  • Ashes 2022

Recent News

  • ‘Dabdaba tha, hai aur rahega’: Hockey India...
  • FIH Pro League: Dominant India thrash Pakistan...

Subscribe Newsletter

Get the latest creative news from india news

  • Privacy Policy
  • Disclaimer
Alluring India 2026